Delivery Order SPE2DB22D3301-SPE2DB23FZ2EJ
Award Date 7/28/23
Potential Completion Date 7/31/23
Potential Value $7.8K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency Troop Support Medical awarded a $7,053.20 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 162 milligram/0.9 milliliter ACTEMRA ACTPEN autoinjectors. The delivery order is for a single line item description of 4561421855 for 0.9 milliliter ACTEMRA ACTPEN autoinjectors and will be performed at Amerisourcebergen's facility in Conshohocken, Pennsylvania between July 6-7, 2023. As a major pharmaceutical distributor, Amerisourcebergen will deliver...
- The Defense Logistics Agency awarded a $11,794.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 8, 2025, for the supply of Actemra Actpen 162 mg/0.9 ml auto-injectors. This competitively awarded contract, with no set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The product will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a $23.6K delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Actemra Actpen 162 mg/0.9 mL auto-injector pens. This competitive award, with no set-aside designation, reflects firm fixed pricing and is scheduled for completion by September 17, 2025. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $19,985.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Actemra Actpen 162 mg/0.9 mL auto-injectors. The order, which represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA, will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 6, 2026. This delivery order was competitively awarded without...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,715.91 to AmerisourceBergen Drug Corp for the supply of Actemra Actpen 162 mg/0.9 ml auto-injectors. This firm fixed-price delivery order, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a non-set-aside competitive award. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $17,900.79 delivery order to AmerisourceBergen Drug Corp for ACTEMRA ACTPEN 162 MG/0.9 ML auto-injector pens on December 17, 2025, with completion expected by December 18, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency Troop Support Medical awarded a $9,029.61 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 162 milligram/0.9 milliliter ACTEMRA ACTPEN autoinjectors. Performance will take place in Conshohocken, Pennsylvania over one day in early August 2023. Amerisourcebergen Corporation, the parent company of Amerisourcebergen Drug Corporation, will deliver the requested pharmaceutical products to support the Defense Logistics Agency's medical supply...
- The Defense Logistics Agency awarded a delivery order valued at $6,690.93 to AmerisourceBergen Drug Corp for Actemra Actpen 162 mg/0.9 ml auto-injector pens. The contract was awarded on September 8, 2025, with an ultimate completion date of September 9, 2025, and employs firm fixed price terms with no set-aside designation. Performance will take place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $15,757.28 to AmerisourceBergen Drug Corp for the supply of Actemra Actpen 162 mg/0.9 mL auto-injector pens. The contract, awarded on September 8, 2025, with an ultimate completion date of September 9, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a $52,071.43 delivery order to AmerisourceBergen Drug Corp on January 30, 2026, for the supply of Actemra ActPen 162 mg/0.9 mL auto-injector pens. This is a firm fixed-price, competitively awarded contract with performance completion scheduled for February 2, 2026, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The contract contains no set-aside designation and represents a single delivery order under AmerisourceBergen's...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB23FZ2EJDelivery Order
The Defense Logistics Agency awarded a $7,797 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ACTEMRA ACTPEN 162 MG/0.9 ML autoinjectors. As a major pharmaceutical distributor, Amerisourcebergen will deliver the 0.9mL ACTEMRA autoinjectors from its Conshohocken, Pennsylvania distribution center to support the Department of Defense's medical readiness and treatment programs. The delivery order was issued under an existing DLA pharmaceutical supply chain contract vehicle and has a period of performance concluding at the end of July 2023. No set aside provisions or subcontracting requirements were specified.
Generated 12/18/23, 7:37 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.8k | 7/28/23 |